Property, Plant and Equipment, Gross of LIGAND PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
LIGAND PHARMACEUTICALS INC quarterly Property, Plant and Equipment, Gross in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • LIGAND PHARMACEUTICALS INC Property, Plant and Equipment, Gross for the quarter ending 31 Dec 2025 was $10,149,000, a 57% decline year-over-year.
Source SEC data
View on sec.gov
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $10,149,000 -$13,252,000 -57% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q4 2024 $23,401,000 +$1,139,000 +5.1% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 $22,262,000 -$345,000 -1.5% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $22,607,000 -$6,615,000 -23% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $29,222,000 +$9,616,000 +49% 31 Dec 2021 10-K 28 Feb 2022 2021 FY
Q4 2020 $19,606,000 +$9,571,000 +95% 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q4 2019 $10,035,000 +$2,498,000 +33% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $7,537,000 +$1,463,000 +24% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $6,074,000 +$2,684,000 +79% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $3,390,000 +$237,000 +7.5% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $3,322,000 +$235,000 +7.6% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $2,684,000 -$403,000 -13% 30 Jun 2016 10-Q 14 Nov 2016 2016 Q2
Q1 2016 $3,391,000 +$310,000 +10% 31 Mar 2016 10-Q 14 Nov 2016 2016 Q1
Q4 2015 $3,153,000 +$24,000 +0.77% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $3,087,000 -$326,000 -9.6% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $3,087,000 -$326,000 -9.6% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $3,081,000 -$1,551,000 -33% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $3,129,000 -$1,611,000 -34% 31 Dec 2014 10-K 14 Nov 2016 2015 FY
Q3 2014 $3,413,000 -$2,366,000 -41% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 $3,413,000 -$2,415,000 -41% 30 Jun 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 $4,632,000 -$1,583,000 -25% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 $4,740,000 -$929,000 -16% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $5,779,000 +$126,000 +2.2% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 $5,828,000 +$302,000 +5.5% 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 $6,215,000 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 $5,669,000 +$443,000 +8.5% 31 Dec 2012 10-K/A 12 Dec 2014 2013 FY
Q3 2012 $5,653,000 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $5,526,000 30 Jun 2012 10-Q/A 14 Nov 2012 2012 Q2
Q4 2011 $5,226,000 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.